Chen Wu
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Molecular Biology top 10%
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- Glycosylation and Glycoproteins Research
Papers in
-
- Circular RNAs in diseases 7
- Epigenetics and DNA Methylation 5
- Extracellular vesicles in disease 5
-
- Cancer-related molecular mechanisms research 14
- MicroRNA in disease regulation 11
- Co-authors
- Jingting Jiang (8 shared papers)Wenwei Hu (5 shared papers)Xiao Zheng (4 shared papers)Qi Wang (2 shared papers)Bin Xu (3 shared papers)You Zhou (4 shared papers)Qi Zhou (2 shared papers)Changping Wu (2 shared papers)
- Journals
- Journal of Cellular and Molecular Medicine (3 papers)International Immunopharmacology (2 papers)Translational Oncology (2 papers)Oncotarget (2 papers)Aging (2 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Chen Wu
73 papers receiving 1.5k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 641
- Molecular Biology 1.0k
- Nephrology 66
- Biomaterials 114
- Immunology 125
Countries citing papers authored by Chen Wu
This map shows the geographic impact of Chen Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chen Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chen Wu more than expected).
Fields of papers citing papers by Chen Wu
This network shows the impact of papers produced by Chen Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chen Wu. The network helps show where Chen Wu may publish in the future.
Co-authors
The 25 scholars most cited alongside Chen Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 78 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling Hit paper breakdown → | 2019 | 425 |
| 2 | 2021 | 120 | |
| 3 | 2019 | 95 | |
| 4 | 2017 | 89 | |
| 5 | 2014 | 60 | |
| 6 | 2010 | 55 | |
| 7 | 2022 | 43 | |
| 8 | 2018 | 42 | |
| 9 | 2017 | 40 | |
| 10 | 2016 | 38 | |
| 11 | 2016 | 37 | |
| 12 | 2019 | 31 | |
| 13 | 2018 | 27 | |
| 14 | 2021 | 24 | |
| 15 | 2017 | 21 | |
| 16 | 2019 | 20 | |
| 17 | 2016 | 20 | |
| 18 | MicroRNA-205 inhibits the apoptosis of renal tubular epithelial cells via the PTEN/Akt pathway in renal ischemia-reperfusion injury. | 2019 | 20 |
| 19 | 2015 | 20 | |
| 20 | 2022 | 17 |
About Chen Wu
Chen Wu is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 78 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (14 papers), MicroRNA in disease regulation (11 papers), Circular RNAs in diseases (7 papers), Ferroptosis and cancer prognosis (7 papers), Epigenetics and DNA Methylation (5 papers), Peptidase Inhibition and Analysis (5 papers), Extracellular vesicles in disease (5 papers) and Metal complexes synthesis and properties (5 papers). The work is most often cited by research in Cancer Research (641 citations), Molecular Biology (1.0k citations), Nephrology (66 citations), Biomaterials (114 citations) and Immunology (125 citations). Chen Wu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Jingting Jiang, Wenwei Hu, Xiao Zheng, Qi Wang, Bin Xu, You Zhou, Qi Zhou, Changping Wu, Lujun Chen and Zhuojun Zheng. Their work appears in journals such as Journal of Cellular and Molecular Medicine, International Immunopharmacology, Translational Oncology, Oncotarget and Aging.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.